CWEB vs. MDP, LABS, HEXO, VIR, ZOM, META, VM, DB, NRTH, and MRV
Should you be buying Charlotte's Web stock or one of its competitors? The main competitors of Charlotte's Web include Medexus Pharmaceuticals (MDP), MediPharm Labs (LABS), HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), Meta Growth (META), Voyageur Pharmaceuticals (VM), Decibel Cannabis (DB), 48North Cannabis (NRTH), and Nuvo Pharmaceuticals (MRV). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Charlotte's Web vs.
Charlotte's Web (TSE:CWEB) and Medexus Pharmaceuticals (TSE:MDP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.
Medexus Pharmaceuticals received 10 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 71.43% of users gave Medexus Pharmaceuticals an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.
In the previous week, Charlotte's Web's average media sentiment score of 0.00 equaled Medexus Pharmaceuticals'average media sentiment score.
Medexus Pharmaceuticals has a consensus price target of C$5.49, suggesting a potential upside of 158.84%. Given Medexus Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Medexus Pharmaceuticals is more favorable than Charlotte's Web.
Charlotte's Web has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, Medexus Pharmaceuticals has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500.
3.3% of Charlotte's Web shares are held by institutional investors. Comparatively, 8.3% of Medexus Pharmaceuticals shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Comparatively, 9.1% of Medexus Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Medexus Pharmaceuticals has a net margin of 3.25% compared to Charlotte's Web's net margin of -66.35%. Medexus Pharmaceuticals' return on equity of 11.07% beat Charlotte's Web's return on equity.
Medexus Pharmaceuticals has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Medexus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Summary
Medexus Pharmaceuticals beats Charlotte's Web on 16 of the 17 factors compared between the two stocks.
Get Charlotte's Web News Delivered to You Automatically
Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Charlotte's Web Competitors List
Related Companies and Tools
This page (TSE:CWEB) was last updated on 4/12/2025 by MarketBeat.com Staff
